InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Fox Allan M., 董事. Officer active across 1 company, notably REGENXBIO Inc.. In total, 6 filings have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €3.7m. Activity tracked since 17 September 2021. The latest transaction was disclosed on 30 May 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Fox Allan M.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
7,768 股0Common StockSEC:0001562180-25-004355:0
4,790 股0Common StockSEC:0001562180-24-004651:0
3,486 股0Common StockSEC:0001562180-23-004896:0
3,010 股0Common StockSEC:0001562180-22-004875:0
61,638 股@ US$34.403750.4% 占其流量Common StockSEC:0001562180-21-007876:0
48,233 股@ US$45.038149.6% 占其流量Common StockSEC:0000899243-21-036773:0
6 条申报中的 6 条
About Fox Allan M.
Allan M. Fox serves as a Director at REGENXBIO Inc. In this role, he participates in the governance of the company and strategic decision-making. Allan brings significant experience in the biopharmaceutical sector, enabling him to contribute to discussions on the direction and performance of the company. His expertise helps REGENXBIO achieve its growth objectives.
